Does physical activity produce clinically significant changes during discontinuation of insulin pump in type 1 diabetic patients?
Authors:
Z. Jankovec; D. Čechurová; V. Česák; M. Krčma; M. Žourek; Z. Rušavý
Authors‘ workplace:
I. interní klinika Lékařské fakulty UK a FN Plzeň, přednosta prof. MU Dr. Martin Matějovič, Ph. D.
Published in:
Vnitř Lék 2013; 59(9): 764-768
Category:
Original Contributions
Overview
Introduction:
Discontinuation of insulin pump treatment (CSII) before, during and after physical activity is a common practice among a number of patients. The aim of the study was to evaluate the course of insulinemia during a 3- hour insulin pump suspension and after consecutive insulin bolus administration, and additionally, to assess the effect of physical activity (mid‑ intensity aerobic exercise).
Patient and methods:
We enrolled 12 patients with diabetes mellitus type 1 in the study (men, mean age 33.4 ± 8.66 years, diabetes duration 16.3 ± 8.76 years, CSII treatment duration 6.9 ± 4.60 years, BMI 25.7 ± 3.75 mg/ m2, HbA1c 8.4 ± 0.95%, total insulin dose 50.3 ± 12.50 IU/ day). The tests were performed after night fasting at usual insulin doses, without serving breakfast and morning bolus dose. In the course of the test, insulin administration by a pump was suspended for 3 hours. Blood for assessment of blood glucose and insulinemia was taken in 30- minute intervals during the test. A test with or without physical exercise on bicycle ergometer was performed in each patient 2 weeks later.
Results:
We did not prove any influence of physical exercise on insulinemia during suspended insulin delivery by an insulin pump. Insulinemia of approximately 50% of the original value persisted for another 90 minutes following insulin pump suspension. A rapid increase in insulinemia occurred after bolus administration in the 180th minute of the test. However, the decrease in blood glucose level did not occur until after another 90 minutes.
Conclusion:
When modifying CSII treatment by reduction or suspension of insulin delivery it is essential to bear in mind the gradual decrease in insulinemia as well as the delay in insulin action following bolus administration.
Key words:
type 1 diabetes mellitus – CSII – insulin pump – insulinemia – physical exercise
Sources
1. Radermecker RP, Scheen AJ. Continuous subcutaneous insulin infusion with short‑ acting insulin analogues or human regular insulin: efficacy, safety, quality of life, and cost‑effectiveness. Diabetes Metab Res Rev 2004; 20: 178– 188.
2. Newton CA, Raskin P. Diabetic ketoacidosis in type 1 and type 2 diabetes mellitus. Clinical and biochemical differences. Arch Intern Med 2004; 164: 1925– 1931.
3. Egger M, Davey Smith G, Stettler C et al. Risk of adverse effects of intensified treatment in insulin‑dependent diabetes mellitus: a meta‑analysis. Diabet Med 1997; 14: 919– 928.
4. Hoogma RP, Hammond PJ, Gomis R et al. Comparison of the effects of continuous subcutaneous insulin infusion (CSII) and NPH‑based multiple daily insulin injections (MDI) on glycaemic control and quality of life: results of the 5- nations trial. Diabet Med 2005; 23: 141– 147.
5. Hanas R, Ludvigsson J. Hypoglycemia and ketoacidosis with insulin pump therapy in children and adolescents. Pediatr Diabetes 2006; 7 (Suppl 4): 32– 38.
6. Weissberg‑ Benchell J, Antisdel‑ Lomaglio J, Seshadri R. Insulin pump therapy. A meta‑analysis. Diabetes Care 2003; 26: 1079– 1087.
7. Guerci B, Meyer L, Salle A et al. Comparison of metabolic deterioration between insulin analog and regular insulin after a 5- hour interruption of continuous subcutaneous insulin infusion in type 1 diabetic patients. JCEM 1999; 84: 2673– 2678.
8. Guilhem I, Leguerrier AM, Lecordier F et al. Technical risk with subcutaneous insulin infusion. Diabetes Metab 2006; 32: 279– 284.
9. Hildebrandt P, Birch KJ, Jensen BM et al. Absorption of subcutaneously infused insulin: Influence of the basal rate pulse interval. Diabetes Care 1985; 8: 287– 289.
10. Hildebrandt P, Birch KJ, Jensen BM et al. Subcutaneous insulin infusion: Chenge in basal infusion rate has no immediate effect on insulin absorption rate. Diabetes Care 1986; 9: 561– 564.
11. Sonnenberg GE, Kemmer FW, Berger M. Exercise in Type 1 (insulin‑dependent) diabetic patients treated with continuous subcutaneous insulin infusion. Diabetologia 1990; 33: 696– 703.
12. Berger M, Cüppers HJ, Hegner H et al. Absorption kinetics and biologic effects of subcutaneously injected insulin preparations. Diabetes Care 1982; 5: 77– 91.
13. Mosekilde E, Jensen K, Binder C et al. Modeling absorption kinetics of subcutaneous injected soluble insulin. J Pharmacokinet Biopharm 1989; 17: 67– 87.
14. Ariza‑ Andraca CR, Altamirano‑ Busta-mante P, Graef A et al. Delayed insulin absorption due to subcutaneous edema. Arch Invest Med 1991; 22: 229– 233.
15. Hildebrandt P. Subcutaneous absorption of insulin in insulin‑dependent diabetic patients: influence of species, physicochemical properties of insulin and physiological factors. Dan Med Bull 1991; 38: 337– 346.
16. Kemmer FW, Berchtold P, Berger M et al. Exercise‑induced fall of blood glucose in insulin‑treated diabetics unrelated to alteration of insulin mobilisation. Diabetes 1979; 28: 1131– 1137.
17. Ferrannini E, Linde B, Faber O. Effect of bicycle exercise on insulin absorption and subcutaneous blood flow in the normal subject. Clin Physiol 1982; 2: 59– 70.
18. Peter J, Luzio SD, Dunseath G et al. Effects of exercise on the absorption of insulin glargine in patients with type 1 diabetes. Diabetes Care 2005; 28: 560– 565.
18. Attia N, Jones TW, Holcombe J et al. Comparison of human regular and lispro insulins after interruption of continuous subcutaneous insulin infusion and in the treatment of acutely decompensated IDDM. Diabetes Care 1998; 21: 817– 821.
19. Guelfi JK, Jones TW, Fournier PA. The decline in blood glucose levels is less with intermitent high‑intensity compared with moderate exercise in individuals with type 1 diabetes. Diabetes Care 2005; 28: 1289– 1294.
20. Admon G, Weinstein Y, Falk B et al. Exercise with and without an insulin pump among children and adolescents with type 1 diabetes mellitus. Pediatrics 2005; 116: e348– e355.
21. The Diabetes Research in Children Network (DirectNet) Study Group. Prevention of hypoglycemia during Exercise in children with type 1 diabetes by suspending basal insulin. Diabetes Care 2006; 29: 2200– 2204.
22. Zisser H. Quantifying the impact of a short‑ interval interruption of insulin‑pump infusion sets on glycemic excursion. Diabetes Care 2008; 31: 238– 239.
23. Heinemann L, Nosek L, Kapitza C et al. Changes in basal insulin infusion rates with subcutaneous insulin infusion. Diabetes Care 2009; 32: 1437– 1439.
Labels
Diabetology Endocrinology Internal medicineArticle was published in
Internal Medicine
2013 Issue 9
Most read in this issue
- Cold agglutinin disease – no response to glucocorticoids and rituximab, what treatment is best for the 3rd line of therapy? Case report and review of the literature
- Food intake regulation – 1st part
- Recommendation of the Czech society of Endocrinology for the treatment of Cushing’s syndrome in adults
- Regional migrating osteoporosis – a case report